- Home
- BDTX vs CGO Comparison
BDTX vs CGO Comparison
Compare BDTX & CGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BDTX | CGO |
|---|---|---|
| Founded | 2014 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.8M | 112.3M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | BDTX | CGO |
|---|---|---|
| Price | $2.60 | $12.93 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $9.67 | N/A |
| AVG Volume (30 Days) | ★ 802.4K | 29.5K |
| Earning Date | 05-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.25% |
| EPS Growth | ★ 130.71 | N/A |
| EPS | ★ 0.39 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $6.83 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.46 | $10.57 |
| 52 Week High | $4.94 | $12.95 |
Technical Indicators
Market Signals| Indicator | BDTX | CGO |
|---|---|---|
| Relative Strength Index (RSI) | 46.92 | 69.01 |
| Support Level | $2.45 | $11.36 |
| Resistance Level | $2.79 | N/A |
| Average True Range (ATR) | 0.20 | 0.23 |
| MACD | -0.06 | 0.03 |
| Stochastic Oscillator | 7.26 | 84.76 |
Price Performance
Historical ComparisonAbout BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
About CGO Calamos Global Total Return Fund
Calamos Global Total Return Fund is a closed-end management investment company. The fund's investment objective is to provide total return through a combination of capital appreciation and current income. The fund invests in equities, convertible securities, and high-yield corporate bonds.